What is SAB Biotherapeutics, Inc. Common Stock's Market Cap?

SAB Biotherapeutics, Inc. Common Stock's Market Cap is $258.4M, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Enterprise Value?

SAB Biotherapeutics, Inc. Common Stock's Enterprise Value is $159.0M, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's EV / EBITDA?

SAB Biotherapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Revenue (TTM)?

SAB Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Net Income (TTM)?

SAB Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$12.8M, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's EBITDA?

SAB Biotherapeutics, Inc. Common Stock's EBITDA is -$68.8M, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?

SAB Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.14, based on as-reported figures from SEC (XBRL) filings.

What is SAB Biotherapeutics, Inc. Common Stock's Net Debt?

SAB Biotherapeutics, Inc. Common Stock's Net Debt is -$99.4M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

SAB Biotherapeutics, Inc. Common Stock

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00YHY0GX0

2.84▼ 0.20 (-6.58%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 3.04
Day's Range: 2.82 – 3.04
52-Week Range: 2.44 – 5.15
Volume: 1.0M
Avg Volume: 727.3K

Share Statistics

Shares Outstanding
Employees: 86
Exchange: XNAS
Listed: 2021-10-22

Share count as of August 3, 2026

SAB Biotherapeutics, Inc. Common Stock (SABS) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about SAB Biotherapeutics, Inc. Common Stock (SABS)

What is SAB Biotherapeutics, Inc. Common Stock's Market Cap?: SAB Biotherapeutics, Inc. Common Stock's Market Cap is $258.4M, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Enterprise Value?: SAB Biotherapeutics, Inc. Common Stock's Enterprise Value is $159.0M, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's EV / EBITDA?: SAB Biotherapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Revenue (TTM)?: SAB Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Net Income (TTM)?: SAB Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$12.8M, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's EBITDA?: SAB Biotherapeutics, Inc. Common Stock's EBITDA is -$68.8M, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?: SAB Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.14, based on as-reported figures from SEC (XBRL) filings.
What is SAB Biotherapeutics, Inc. Common Stock's Net Debt?: SAB Biotherapeutics, Inc. Common Stock's Net Debt is -$99.4M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · SABSAs-filed SEC (XBRL) data